{"id":229759,"date":"2023-08-11T00:00:00","date_gmt":"2023-08-11T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/products\/research-reports\/report\/47041092-medtech-enterprise-solutions-market-insights-united\/"},"modified":"2026-03-31T10:12:14","modified_gmt":"2026-03-31T10:12:14","slug":"47041092-medtech-enterprise-solutions-market-insights-united-states","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/47041092-medtech-enterprise-solutions-market-insights-united-states\/","title":{"rendered":"Enterprise Solutions &#8211; Market Insights &#8211; United States"},"content":{"rendered":"<p>Although the US enterprise solution market was negatively impacted during the height of the <abbr title=\"Coronavirus Disease 2019\">COVID-19<\/abbr> global pandemic, the market continues to recover and will ultimately see robust growth through 2032. The market growth will be driven by the increasing movement toward value-based healthcare and effective <abbr data-abbreviation-entity=\"9935\" title=\"Population Health Management\">PHM<\/abbr> in the US, as well as adoption of hybrid and full-cloud systems, and consolidation among healthcare facilities that has increased the uptake of <abbr title=\"Health Care Information Technology\">HCIT<\/abbr> solutions.<\/p>\n<p>This Medtech 360 Report provides comprehensive data and analysis on the state of the market for enterprise solutions in the US from 2019 through 2032.<\/p>\n<p class=\"question-statement\"><strong>Hybrid and full-cloud <abbr title=\"Vendor Neutral Archive\">VNA<\/abbr> and enterprise viewers are seeing favorable adoption among healthcare facilities in the US.<\/strong><\/p>\n<p class=\"question-statement\">What factors are promoting the uptake of hybrid and full-cloud <abbr title=\"Vendor Neutral Archive\">VNA<\/abbr> and enterprise viewers?<\/p>\n<p class=\"question-statement\">Which competitors are offering these solutions in this market?<\/p>\n<p class=\"question-statement\"><strong>Despite the large size of enterprise <abbr title=\"Picture Archiving and Communication System(s)\">PACS<\/abbr> market in the US enterprise solution market, the <abbr title=\"Vendor Neutral Archive\">VNA<\/abbr> and enterprise viewers market is bound to grow, limiting enterprise <abbr title=\"Picture Archiving and Communication System(s)\">PACS<\/abbr> market growth.<\/strong><\/p>\n<p>What are the key differences between <abbr title=\"Vendor Neutral Archive\">VNA<\/abbr> and enterprise <abbr title=\"Picture Archiving and Communication System(s)\">PACS<\/abbr>, and how do these differences contribute to the value proposition of each technology?<\/p>\n<p>What factors limit the uptake of traditional enterprise <abbr title=\"Picture Archiving and Communication System(s)\">PACS<\/abbr>? What pushes the demand for <abbr title=\"Vendor Neutral Archive\">VNA<\/abbr> and enterprise viewers during the forecast years?<\/p>\n<p><b>The US enterprise <\/b><strong>solution market<\/strong><b> is a saturated market dominated by international competitors.<\/b><\/p>\n<p>How will mergers and acquisitions change the competitive landscape of enterprise solution market?<\/p>\n<p>What strategies will smaller competitors adopt to gain market shares in the US enterprise solution market?<\/p>\n<p class=\"question-statement\"><strong>Cybersecurity in the <abbr title=\"Health Care Information Technology\">HCIT<\/abbr> sector is an important topic of discussion, and security issues related to unprotected servers have always posed a threat to the market growth.<\/strong><\/p>\n<p class=\"question-statement\">What security vulnerabilities do enterprise solutions have that could negatively impact market growth?<\/p>\n<p>Which market segment is affected the most by the growing threat of data breaches and cybersecurity?<\/p>\n","protected":false},"template":"","class_list":["post-229759","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-enterprise-solutions","medtech-therapy-area-healthcare-it","medtech-geography-united-states","medtech-date-976"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/229759","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/229759\/revisions"}],"predecessor-version":[{"id":281540,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/229759\/revisions\/281540"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=229759"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}